Bullous pemphigoid occurring during efalizumab treatment for psoriasis: A paradoxical auto-immune reaction?

Dermatology

Volumn 219, Issue 1, 2009, Pages 89-90

  Monnier Murina, Karine ^a   Du Thanh, Aurélie ^a   Merlet Albran, Séverine ^a   Guillot, Bernard ^a   Dereure, Olivier ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Bullous pemphigoid; Efalizumab; Psoriasis

Indexed keywords

ANTINUCLEAR ANTIBODY; CLOBETASOL PROPIONATE; COMPLEMENT COMPONENT C3; EFALIZUMAB; IMMUNOGLOBULIN G; METHOTREXATE; RHEUMATOID FACTOR;

AGED; BASEMENT MEMBRANE; BULLOUS PEMPHIGOID; CASE REPORT; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IMMUNITY; INFLAMMATORY CELL; LETTER; LUPUS LIKE SYNDROME; MUCOSA; PANCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; SKIN MANIFESTATION; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD11; AUTOIMMUNITY; HUMANS; MALE; PEMPHIGOID, BULLOUS; PSORIASIS;

EID: 67651108975     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207792     Document Type: Letter

References (8)

1. Scheinfeld N: Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin Drug Saf 2006; 5: 197-209.
2. Kwan JM, Reese AM, Trafeli JP: Delayed autoimmune hemolytic anemia in efalizumab-treated psoriasis. J Am Acad Dermatol 2008; 58: 1053-1055.
3. Tom WL, Miller MD, Hurley MY, Suneja T, Kudva G, Leonardi CL, Obadiah JM: Efalizumab-induced autoimmune pancytopenia. Br J Dermatol 2006; 155: 1045-1047.
4. Durox H, Sparsa A, Loustaud-Ratti V, Prey S, Gondran G, Manea P, Vidal E, Bedane C: Efalizumab-induced lupus-like syndrome. Acta Derm Venereol 2008; 88: 270-271.
5. Firmin D, Roguedas AM, Lemasson G, Abgrall JF, Misery L: Eczematous dermatosis and thrombocytosis induced by efalizumab: two new side effects. Dermatology 2008; 217: 203-206.
6. Santos-Juanes J, Coto-Segura P, Mallo S, Galache C, Soto J: Multiple eruptive dermatofibromas in a patient receiving efalizumab. Dermatology 2008; 216: 363. (Pubitemid 351630106)
7. Nosbaum A, Allombert-Blaise C, Ly A, Jullien D, Faure M, Claudy A, Simon M: Pancytopénie au cours d'un traitement par éfalizumab. Ann Dermatol Venereol 2008; 135: 407-408.
8. Wilczek A, Sticherling M: Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol 2006; 45: 1353-1357.